Table 2.

Characteristics of men diagnosed with prostate cancer between 2002 and 2006 NPCR in Sweden, by T2DM status

No diabetes (N = 42,871)Diabetes (N = 1,539)
Age, mean (SD)70.2 (9.3)72.4 (8.0)
T-stage,a n (%)
 T1ab2,503 (5.8)125 (8.1)
 T1c15,762 (36.8)479 (31.1)
 T213,034 (30.4)474 (30.8)
 T3–T410,717 (25.0)425 (27.6)
 M-stage, n (%)
 M010,551 (24.6)371 (24.1)
 MX, PSA < 100/missing26,455 (61.7)926 (60.2)
 M1 or PSA ≥ 1005,865 (13.7)242 (15.7)
PSA level,a n (%)
 PSA < 42,633 (6.1)94 (6.1)
 4 ≤ PSA < 1015,134 (35.3)455 (29.6)
 10 ≤ PSA < 209,570 (22.3)332 (21.6)
 20 ≤ PSA < 507,122 (16.6)290 (18.8)
 500 ≤ PSA < 1003,070 (7.2)140 (9.1)
 PSA ≥ 1004,440 (10.4)185 (12.0)
 PSA, median (Q1–Q3)12 (6.7–31)15 (7.2–38)
Gleason score,a n (%)
 2—620,286 (47.3)602 (39.1)
 713,477 (31.4)514 (33.4)
 8—108,284 (19.3)395 (25.7)
Prostate cancer risk categories,a n (%)
 Low risk11,533 (26.9)318 (20.7)
 Intermediate risk12,850 (30.0)437 (28.4)
 High risk8,520 (19.9)365 (23.7)
 Regionally metastatic3,113 (7.3)133 (8.6)
 Distant metastases5,865 (13.7)242 (15.7)
SES, n (%)
 High21,478 (50.1)658 (42.8)
 Low20,826 (48.6)864 (56.1)
 Not gainfully employed/unclassified/missing567 (1.3)17 (1.1)
Civil status, n (%)
 Married29,392 (68.6)1015 (66.0)
 Widower4,345 (10.1)169 (11.0)
 Divorced5,499 (12.8)195 (12.7)
 Not married3,635 (8.5)160 (10.4)
  • aNumber to not add to total because of missing values.